STOCK TITAN
  1. Home
  2. Sec-filings
  3. NPCE
  4. [Form 4] Neuropace, Inc. Insider Trading Activity

NeuroPace Board Member Shows Confidence with Growing Stock Position

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Joseph Lacob, Director at NeuroPace, reported multiple acquisitions of common stock through the company's non-employee director compensation policy in lieu of quarterly retainer fees from June 2023 to June 2025.

Key transactions include:

  • Nine separate acquisitions totaling 11,696 shares at prices ranging from $4.49 to $13.20
  • Most recent acquisition: 1,080 shares at $10.41 on June 21, 2025
  • Current direct ownership: 12,080 shares
  • Significant indirect ownership through: - Lacob Ventures LLC: 128,174 shares - LCT18 Investments: 223,554 shares

Total beneficial ownership (direct and indirect) amounts to 363,808 shares, demonstrating substantial insider stake in the company. All direct acquisitions were made as compensation for board service rather than open market purchases.

Positive

  • Director Joseph Lacob consistently acquired shares as part of compensation over multiple quarters, demonstrating alignment with shareholder interests and confidence in the company
  • The director maintains substantial indirect ownership of 351,728 shares through Lacob Ventures LLC and LCT18 Investments, indicating significant long-term commitment

Negative

  • None.
Insider LACOB JOSEPH
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 1,080 $10.41 $11K
Grant/Award Common Stock 935 $12.02 $11K
Grant/Award Common Stock 975 $11.53 $11K
Grant/Award Common Stock 1,614 $6.97 $11K
Grant/Award Common Stock 1,488 $7.56 $11K
Grant/Award Common Stock 852 $13.20 $11K
Grant/Award Common Stock 1,091 $10.31 $11K
Grant/Award Common Stock 1,156 $9.73 $11K
Grant/Award Common Stock 2,505 $4.49 $11K
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 12,080 shares (Direct); Common Stock — 128,174 shares (Indirect, See footnote)
Footnotes (1)
  1. These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Shares are held by Lacob Ventures LLC. Shares are held by LCT18 Investments.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LACOB JOSEPH
(Last) (First) (Middle)
C/O NEUROPACE, INC.
455 N. BERNARDO AVENUE
(Street)
MOUNTAIN VIEW CA 94043
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NeuroPace Inc [ NPCE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/30/2023 A 2,505(1) A $4.49 2,889 D
Common Stock 09/29/2023 A 1,156(1) A $9.73 4,045 D
Common Stock 12/29/2023 A 1,091(1) A $10.31 5,136 D
Common Stock 03/29/2024 A 852(1) A $13.2 5,988 D
Common Stock 06/28/2024 A 1,488(1) A $7.56 7,476 D
Common Stock 09/30/2024 A 1,614(1) A $6.97 9,090 D
Common Stock 12/21/2024 A 975(1) A $11.53 10,065 D
Common Stock 03/21/2025 A 935(1) A $12.02 11,000 D
Common Stock 06/21/2025 A 1,080(1) A $10.41 12,080 D
Common Stock 128,174 I See footnote(2)
Common Stock 223,554 I See footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.
2. Shares are held by Lacob Ventures LLC.
3. Shares are held by LCT18 Investments.
/s/ Leah Akin, Attorney-in-Fact 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

How many NPCE shares did Director Joseph Lacob acquire in June 2025?

According to the Form 4 filing, Director Joseph Lacob acquired 1,080 shares of NPCE common stock on June 21, 2025, at a price of $10.41 per share.

What is Joseph Lacob's total direct ownership of NPCE stock after the latest transaction?

Following the June 21, 2025 transaction, Joseph Lacob directly owned 12,080 shares of NPCE common stock.

How many NPCE shares does Joseph Lacob indirectly own through his affiliated entities?

Joseph Lacob indirectly owns a total of 351,728 shares of NPCE through two entities: 128,174 shares through Lacob Ventures LLC and 223,554 shares through LCT18 Investments.

Why did Joseph Lacob receive NPCE shares throughout 2023-2025?

The shares were issued to Lacob pursuant to NeuroPace's non-employee director compensation policy in lieu of quarterly retainer fees, as indicated in footnote 1 of the filing.

What was the price range of NPCE shares issued to Joseph Lacob during 2023-2025?

The prices of shares issued to Lacob ranged from $4.49 (June 2023) to $13.20 (March 2024), with the most recent issuance in June 2025 at $10.41 per share.